ZION
56
4
TJX
59
5
XRX
57
-2
PAYX
54
9
NUE
43
2
EQR
39
2
STI
12
-7
SYK
55
-2
D
37
2
F
42
2
MS
72
2
EW
57
2
KSS
42
3
GILD
58
2
NI
70
2
CA
32
3
VIX
15
7
JPM
64
2
JCI
44
2
NRG
37
-2
ZION
56
4
TJX
59
5
XRX
57
-2
PAYX
54
9
NUE
43
2
EQR
39
2
STI
12
-7
SYK
55
-2
D
37
2
F
42
2
MS
72
2
EW
57
2
KSS
42
3
GILD
58
2
NI
70
2
CA
32
3
VIX
15
7
JPM
64
2
JCI
44
2
NRG
37
-2
Financhill
Back

Regeneron Pharmaceuticals Vs. Nukkleus Industry Stock Comparison

Sell
45

REGN
Regeneron Pharmaceuticals

Last Price:
$714.54
Seasonality Move:
9.99%
Sell
46

NUKK
Nukkleus

Last Price:
$39.19
Seasonality Move:
-19.41%
Sell
45
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $716.68. The Score for REGN is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $40.02. The Score for NUKK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $716.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $40.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKK is experiencing slight buying pressure.

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -27.19 Sell
Relative Strength Index (14 RSI): 34.69 Sell
Chaikin Money Flow: 377563 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (720.58 - 766.88) Sell
Bollinger Bands (100): (789.67 - 1133.55) Sell

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.45 Buy
Relative Strength Index (14 RSI): 72.52 Buy
Chaikin Money Flow: 447278 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (-5.94 - 30.1) Buy
Bollinger Bands (100): (-5.23 - 14.69) Buy

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 716.99 Sell
20-day SMA: 743.24 Sell
50-day SMA: 808.56 Sell
200-day SMA: 977.12 Sell
8-day EMA: 720.58 Sell
20-day EMA: 741.69 Sell
50-day EMA: 811.56 Sell
200-day EMA: 927.94 Sell

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.31 Buy
20-day SMA: 14.67 Buy
50-day SMA: 7.21 Buy
200-day SMA: 5.25 Buy
8-day EMA: 33.29 Buy
20-day EMA: 20.74 Buy
50-day EMA: 11.08 Buy
200-day EMA: 12.59 Buy

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.58 per share, and a decrease next year of $0.14 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):